About Baxter
Baxter is a publicly listed company based in Deerfield (United States) founded in 1931, and was acquired by Warburg Pincus in October 2023. Biosciences, medication delivery, and renal products are developed and marketed. The company has 38,000 employees. Baxter has completed 20 acquisitions, including AesRx, ApaTech and Caremark. Its chief executive, as recorded, is Jose E Almeida. Its website baxter.com draws about 402 thousand monthly visits. Baxter offers products and services including Infusion Pumps, Nutritional Products, and Respiratory Therapies. Its focus areas include Diversified Medical Devices and Devices. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1931 and headquartered in Deerfield, United States, products for treating hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions are developed, manufactured, and marketed by the company. Operations are divided into BioScience, Medication Delivery, and Renal segments, covering recombinant proteins, intravenous solutions, infusion systems, and renal therapies. In 2023, annual revenues of 15.05 billion were recorded alongside a net loss of 2.46 billion.
- Headquarters Deerfield, United States
- Employees 38,000
- Stage Acquired
- SectorsHealthcare
- Website category Health
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website baxter.com
- Social LinkedIn X Facebook YouTube
- Acquired by Warburg Pincus (Oct 2023)
- Legal Name Baxter International Inc.
- Annual Revenue$11.24 B (USD)5.72as on Dec 31, 2025
- Net Profit-$1.05 B (USD)-62.4as on Dec 31, 2025
- EBITDA$1.67 B (USD)-0.59as on Dec 31, 2025
- Latest Funding Round$3.09M (USD), Grant
May 2022
- InvestorsWarburg Pincus
& 3 more
- Employee Count38,000
- Investments & AcquisitionsAesRx
& 19 more
- Acquired byWarburg Pincus
(Oct 2023)
Associated legal entities of Baxter
Baxter is associated with 3 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Baxter Innovations And Business Solutions Private Limited CIN U74999KA2017PTC109068 | Active | 29 Dec 2017 | Bangalore, Karnataka | ₹609 Cr | 1,014 | 4 | View details |
| Baxter Pharmaceuticals India Private Limited CIN U24230GJ2005PTC046211 | Active | 08 Jun 2005 | Vasana Chacharwadi, Gujarat | ₹672 Cr | 1,179 | 6 | View details |
| Baxter India Private Limited CIN U33112HR1996PTC038528 | Active | 11 Jun 1996 | Gurgaon, Haryana | ₹505 Cr | 245 | 5 | View details |
Products & Services of Baxter
Baxter offers a comprehensive portfolio of products and services, including Infusion Pumps, Nutritional Products, and Respiratory Therapies.
Devices for delivering medications and fluids to patients
Solutions for patients unable to self-feed
Products to simplify breathing treatments
Apps and channels of Baxter
its YouTube channel BaxterInternational has 15.3K subscribers and 30 videos.
Videos from Baxter
The most watched videos on Baxter's YouTube channel, BaxterInternational (15.3K subscribers). Click a video to play it here.
More on BaxterInternational.
Funding Insights of Baxter
- Total Rounds 6
- Last Round Grant β $3.09M
- Investors Count 2
All 6 funding rounds of Baxter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $3.09M | Grant | β | β | |
| Jun 2021 | Grant | β | β | ||
| Jun 2019 | Grant | β | β | ||
| May 2019 | $1.68B | Debt – Conventional | β | β | β |
| Jan 2019 | $302,805 | Grant | β | β | |
| Jun 2012 | Grant | β | β |
4 investors in total: 4 institutional.
Investors in Baxter
Baxter has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Warburg Pincus, European Union and BMBF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Private equity firm focused on multiple sectors | adventinternational.com | Sao Paulo, Brazil | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Education and research policies are overseen by the ministry. | 1955 | bmbf.de | Berlin, Germany |
Investor details for Baxter
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Baxter
The boards of the 3 registered companies of Baxter currently have 12 directors; the longest-serving is Karuna Kapoor, appointed in 2020. 72 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Karuna Kapoor DIN 08770423 | Director | 06 Jul 2020 | 6 yrs 4 mo | Baxter Innovations And Business Solutions Private Limited |
| Shalini Naagar DIN 03230079 | Director | 29 Dec 2020 | 5 yrs 10 mo | Baxter India Private Limited |
| Suresh Kumar Surapalannair DIN 09089354 | Director | 05 Mar 2021 | 5 yrs 8 mo | Baxter Innovations And Business Solutions Private Limited |
| Sanju Dhawan DIN 09224741 | Director | 09 Jul 2021 | 5 yrs 4 mo | Baxter Pharmaceuticals India Private Limited |
| Ajay Bijani DIN 10452933 | Director | 04 Jan 2024 | 2 yrs 10 mo | Baxter India Private Limited |
| Anil Kumar Madugulla DIN 10462398 | Director | 24 Jan 2024 | 2 yrs 9 mo | Baxter Innovations And Business Solutions Private Limited |
| Abhinav Kashyap DIN 10491768 | Director | 14 Feb 2024 | 2 yrs 8 mo | Baxter Innovations And Business Solutions Private Limited |
| Anuranjan Naresh DIN 02822684 | Additional Director | 01 Oct 2024 | 2 yrs 1 mo | Baxter Pharmaceuticals India Private Limited, Baxter India Private Limited |
| Tripti Sapra DIN 10776278 | Additional Director | 01 Oct 2024 | 2 yrs 1 mo | Baxter Pharmaceuticals India Private Limited, Baxter India Private Limited |
| Anurag Bharatkumar Pachchigar DIN 10776295 | Additional Director | 01 Oct 2024 | 2 yrs 1 mo | Baxter Pharmaceuticals India Private Limited |
| Gurjeet Singh Bedi DIN 10875091 | Additional Director | 23 Dec 2024 | 1 yr 10 mo | Baxter Pharmaceuticals India Private Limited |
| Ashwin Prakash Upasane DIN 11132124 | Additional Director | 18 Jun 2025 | 1 yr 4 mo | Baxter Pharmaceuticals India Private Limited |
People of Baxter
820 people are tracked at Baxter (298 in leadership, 10 in board & advisors, 512 in team); the tracked headcount is 38,000.
| Name | Role | Group |
|---|---|---|
Jose E Almeida | CEO | Leadership |
Sasha Davis | VP Human Resources, Baxter Pharmaceuticals | Leadership |
Tobi Karchmer | Chief Medical And Scientific Officer | Leadership |
James Borzi | EVP & Chief Supply Chain Officer | Leadership |
David Bondi | Chief Procurement Officer | Leadership |
Konstantin Butskiy | Vice President, Finance - Global Financial Planning & Analysis And Global Integrated Supply Chain | Leadership |
Julio Rodriguez Obaldia | Plant Director | Leadership |
Shani Noel | Director, Market Access & Managed Care | Leadership |
Christoph Schmotz | Vice President R&d PSS & GSS | Care & Connectivity Solutions | Site Lead Munich | Leadership |
Muneeb Ruhi | VP Canada - Digital Health & Commercial Operations | Leadership |
Simone Diorio | VP Quality Medical Products And Therapies (1700 Staff) | Leadership |
Graham Vonder Haar | Sr Director, Global Strategy & Analytics - Pharmaceuticals | Leadership |
Gaganjot Gill | Director Of Quality - Multi-site Leadership | Leadership |
Bhavesh Padmani | Director, Digital Health R&d | Leadership |
Brit Baird | Director Regulatory Affairs And Quality Assurance | Leadership |
Jeanne Mason | Evp, Chief Human Resources Officer | Leadership |
Nancy Laue | Vice President, Commercial Operations - U.s. And Latin America | Leadership |
Ronald Tee | APAC Director Of Operations | Leadership |
Adrienne Babb | Director Of Commercial Training & Development | Leadership |
Stephen Daley | Vice President And General Manager, Baxter Cardiology | Leadership |
800 more people are available in the full profile.
Complete people profiles for Baxter
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Baxter
Baxter is a publicly listed company on the NYSE with ticker symbol BAX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 Mar 2021
- Listed onLSE: 0QK8
- Listed entityBaxter International Inc.
- Exchange sectorHealth technology
- ISINUS0718131099
- Share price$24.89 (+0.44% on the day) · 2026-10-13
- Market capitalisation$12.87B
- EPS (diluted, trailing year)$-1.93
- Dividend yield0.16%
- Volume (last session)3,249,507
Financials of Baxter
Figures of Baxter Pharmaceuticals India Private Limited, the primary company behind Baxter, for FY 2025. Revenue was ₹672 Cr (+20% year on year). Net profit was ₹16.49 Cr (2% margin). EBITDA was ₹98.59 Cr (15% margin). Revenue has grown at a compounded annual rate of -7% over three years and -4% over five years.
- ₹672 CrRevenue · FY 2025 · +20% YoY
- ₹16.49 CrNet profit · 2% margin
- ₹98.59 CrEBITDA · 15% margin
- ₹5.7 LakhPaid-up capital
- 1,179Employees (provident fund records)
- -7%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $11.24B | -$1.05B | $1.67B |
| 2024 | $10.64B | -$649.0M | $1.68B |
| 2023 | $10.36B | -$226.0M | $1.89B |
| 2022 | $14.51B | -$2.43B | $3.02B |
| 2021 | $12.78B | $1.28B | $2.97B |
Balance sheet, profit and loss, cash flow and ratios of Baxter Pharmaceuticals India Private Limited are on its company page.
Detailed financial statements for Baxter
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Baxter
Baxter has strategically engaged in corporate development activities, having acquired 20 companies. Notable acquisitions include AesRx, ApaTech and Caremark.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Body worn sensor to remotely monitor chronic diseases vitals, EvoNexus Alum. | tosense.com | San Diego, United States | 2014 | Apr 2020 | β’β’β’β’ | |
Hemostat and sealant products for surgical adhesion prevention are supplied. | seprafilm.us | Deerfield, United States | 2009 | Dec 2019 | $350M | |
Non-invasive cardiac output and hemodynamic monitoring devices are developed. | cheetah-medical.com | Newton, United States | 2001 | Sep 2019 | $230M | |
Medical devices are manufactured for multiple therapeutic areas. | trueprocess.com | Milwaukee, United States | 2004 | Aug 2017 | β’β’β’β’ | |
Developer of natural resource and energy projects in South Eastern Europe | clarisinj.com | Ahmedabad, India | 2005 | Jul 2017 | $625M | |
Pharmaceutical products are manufactured and distributed by Sigma Tau. | sigma-tau.it | Rome, Italy | 1957 | May 2015 | β’β’β’β’ | |
Therapeutics for autoimmune diseases are developed by SuppreMol. | suppremol.com | Planegg, Germany | 2002 | Mar 2015 | $223.71M | |
Prophylactic treatments for sickle cell disease were developed. | aesrx.com | Newton, United States | 2009 | Jul 2014 | β’β’β’β’ | |
Management, surveillance and reporting software for antimicrobial stewardship and infection prevention | icnetsystems.com | Chicago, United States | 2011 | Jun 2014 | β’β’β’β’ | |
Continuous urine output monitoring systems are developed for critical care. | flowsensemedical.com | Misgav, Israel | 2009 | Sep 2013 | $9.5M |
Complete acquisition details for Baxter
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Baxter
15 dated milestones of Baxter across 92 years, from founding to its latest funding, stage changes and deals.
- Founded Baxter is founded.
- Funding First funding round.
- Acquisition Acquires FlowSense Medical.
- Acquisition Acquires ICNet Systems.
- Acquisition Acquires AesRx.
- Acquisition Acquires SuppreMol.
- Acquisition Acquires Sigma Tau.
- Acquisition Acquires Claris Injectables.
- Acquisition Acquires True Process.
- Acquisition Acquires Cheetah Medical.
- Acquisition Acquires Seprafilm.
- Acquisition Acquires toSense.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $3.1M.
- Exit Acquired by Warburg Pincus.
Competitors of Baxter
Baxter has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | ||
| bostonscientific.com | 1979 | Marlborough, United States | 63,359 | Wide range of medical devices |
Detailed competitors of Baxter
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Baxter
The website of Baxter (baxter.com) receives about 401.8K visits a month and ranks #127,908 among all websites worldwide, #3,834 in Health.
- Monthly visits401.8K
▲ 15.6% vs previous month
- Unique visitors122.2K
per month
- Global rank#127,908
among all websites
- Category rank#3,834
Health · Health
- Bounce rate37%
- Pages per visit3.4
- Average visit3 min 46 sec
- DevicesDesktop 55% Β· Mobile 45%
Websites whose visitors overlap most with Baxter. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abbott.com | 100% | 917.2K | #65,577 | View details | |
baxterhealthcare.co.uk | baxterhealthcare.co.uk | 96% | #2,565,472 | β | |
| lilly.com | 88% | 4.9M | #13,252 | View details | |
| medtronic.com | 85% | 2.6M | #22,622 | View details | |
| hospira.com | 83% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Baxter
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Baxter (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Baxter
Complete news archive for Baxter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baxter
Baxter was founded in 1931 and raised its 1st funding round 81 years after it was founded.
Baxter is headquartered in Deerfield, United States.
Jose E Almeida is the CEO of Baxter, as recorded in our data.
Baxter has 38,000 employees.
Annual revenue of Baxter is $11.24B as on Dec 31, 2025.
Founded in 1931 and headquartered in Deerfield, United States, products for treating hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions are developed, manufactured, and marketed by the company. Operations are divided into BioScience, Medication Delivery, and Renal segments, covering recombinant proteins, intravenous solutions, infusion systems, and renal therapies. In 2023, annual revenues of 15.05 billion were recorded alongside a net loss of 2.46 billion.
Baxter's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Baxter offers Infusion Pumps, Nutritional Products, and Respiratory Therapies.
Yes, Baxter is publicly traded on NYSE under the ticker symbol BAX.
Baxter has 4 investors. Key investors include Warburg Pincus, European Union, BMBF, and Advent International.
Baxter is associated with 3 legal entities: Baxter Pharmaceuticals India Private Limited, Baxter India Private Limited, Baxter Innovations And Business Solutions Private Limited.

